Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers

By Takahashi Yuri   Miyoshi Yasuo   Morimoto Koji   Taguchi Tetsuya   Tamaki Yasuhiro   Noguchi Shinzaburo  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 8, 2007-08 ,pp. : 501-509

Springer Publishing Company

Access to resources Recommend Favorite

ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma

By                    

International Journal of Oncology, Vol. 42, Iss. 5, 2013-01 ,pp. : 1551-1559

Spandidos Publications

Access to resources Recommend Favorite

Differences in Yes-associated protein and mRNA levels in regenerating liver and hepatocellular carcinoma

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 410-414

Spandidos Publications

Access to resources Recommend Favorite

mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma

By                        

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 3155-3161

Spandidos Publications

Access to resources Recommend Favorite

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma

By Birkeland Einar   Busch Christian   Berge Elisabet   Geisler Jürgen   Jönsson Göran   Lillehaug Johan   Knappskog Stian   Lønning Per  

Clinical and Experimental Metastasis, Vol. 30, Iss. 7, 2013-10 ,pp. : 867-876

Springer Publishing Company

Access to resources Recommend Favorite